Zentek Ltd. (NASDAQ:ZTEK) Short Interest Update

Zentek Ltd. (NASDAQ:ZTEK) was the recipient of a large growth in short interest in July. As of July 31st, there was short interest totaling 94,700 shares, agrowthof35.5% from the July 15th total of 69,900 shares. Based on an average trading volume of 38,000 shares, the short-interest ratio is presently 2.5 days. Approximately0.1% of the company’s stock are sold short. Approximately0.1% of the company’s stock are sold short. Based on an average trading volume of 38,000 shares, the short-interest ratio is presently 2.5 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Zentek stock. Two Sigma Securities LLC bought a new position in Zentek Ltd. (NASDAQ:ZTEK) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 33,128 shares of the company’s stock, valued at approximately $31,000. Hedge funds and other institutional investors own 0.77% of the company’s stock.

Zentek Stock Down 2.4%

Shares of NASDAQ:ZTEK opened at $0.7201 on Wednesday. Zentek has a 52-week low of $0.4999 and a 52-week high of $1.8411. The firm has a market capitalization of $75.40 million, a P/E ratio of -14.40 and a beta of 0.47. The stock has a 50 day moving average price of $1.04 and a 200-day moving average price of $1.17. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.00 and a current ratio of 1.62.

Zentek (NASDAQ:ZTEK) last announced its earnings results on Thursday, August 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. Zentek had a negative return on equity of 55.41% and a negative net margin of 981.17%.The firm had revenue of $0.04 million during the quarter.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.